The role of FSH in body composition in hematopoietic cell transplant recipients

Erica J. Roelofs; Donald R. Dengel; Qi Wang; James S. Hodges; Julia Steinberger; Scott Baker

doi:10.1111/petr.14130

The role of FSH in body composition in hematopoietic cell transplant recipients

Erica J. Roelofs, Donald R. Dengel, Qi Wang, James S. Hodges, Julia Steinberger, Scott Baker

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

BACKGROUND: Childhood cancer survivors who received a hematopoietic cell transplantation (HCT) are at increased risk for follicle-stimulating hormone (FSH) abnormalities, which may have a significant negative impact on bone health and body composition. This study's purpose was to examine FSH and body composition in HCT recipients, non-HCT recipients and healthy controls.

METHODS: The study included HCT recipients (n = 24), non-HCT recipients (n = 309), and a control group of healthy siblings (n = 211) all aged 9-18 years. A fasting blood sample was collected to measure FSH. All participants underwent a dual X-ray absorptiometry scan to assess total and regional percent fat, lean mass (LM), fat mass (FM), bone mineral content (BMC), bone mineral density (BMD), and visceral adipose tissue (VAT) mass.

RESULTS: FSH was significantly higher in HCT recipients compared to non-HCT recipients and healthy controls. HCT recipients had significantly lower total body weight, total LM, arm and leg LM, BMC and BMD compared to non-HCT recipients and healthy controls (p < .05). Non-HCT recipients had significantly higher total, trunk, android, gynoid, arm and leg FM compared to healthy controls. Also, healthy controls had significantly lower VAT mass compared to non-HCT recipients.

CONCLUSIONS: This study's results show that HCT recipients have significant reductions in BMD, worse body composition, and abnormal FSH levels compared to non-HCT recipients and healthy controls.

Original language	English (US)
Article number	e14130
Journal	Pediatric transplantation
Volume	26
Issue number	1
Early online date	Sep 5 2021
DOIs	https://doi.org/10.1111/petr.14130
State	Published - Feb 2022

Bibliographical note

Funding Information:
Supported by the National Institutes of Health (grants R01 CA113930 [to J.S.] and R01CA112530 [to K.S.B.]), the General Clinical Research Center Program (grant M01‐RR00400), National Center for Research Resources (grant 1UL1‐RR033183), and the Clinical and Translational Science Institute at the University of Minnesota‐Twin Cities (grant UL1TR000114). Statistical support was provided by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114.

Publisher Copyright:
© 2021 Wiley Periodicals LLC.

PubMed: MeSH publication types

Journal Article

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1111/petr.14130

Find It

Find It at U of M Libraries

Cite this

@article{5814609bf4174301b059eda4e6a32d13,

title = "The role of FSH in body composition in hematopoietic cell transplant recipients",

abstract = "BACKGROUND: Childhood cancer survivors who received a hematopoietic cell transplantation (HCT) are at increased risk for follicle-stimulating hormone (FSH) abnormalities, which may have a significant negative impact on bone health and body composition. This study's purpose was to examine FSH and body composition in HCT recipients, non-HCT recipients and healthy controls.METHODS: The study included HCT recipients (n = 24), non-HCT recipients (n = 309), and a control group of healthy siblings (n = 211) all aged 9-18 years. A fasting blood sample was collected to measure FSH. All participants underwent a dual X-ray absorptiometry scan to assess total and regional percent fat, lean mass (LM), fat mass (FM), bone mineral content (BMC), bone mineral density (BMD), and visceral adipose tissue (VAT) mass.RESULTS: FSH was significantly higher in HCT recipients compared to non-HCT recipients and healthy controls. HCT recipients had significantly lower total body weight, total LM, arm and leg LM, BMC and BMD compared to non-HCT recipients and healthy controls (p < .05). Non-HCT recipients had significantly higher total, trunk, android, gynoid, arm and leg FM compared to healthy controls. Also, healthy controls had significantly lower VAT mass compared to non-HCT recipients.CONCLUSIONS: This study's results show that HCT recipients have significant reductions in BMD, worse body composition, and abnormal FSH levels compared to non-HCT recipients and healthy controls.",

author = "Roelofs, {Erica J.} and Dengel, {Donald R.} and Qi Wang and Hodges, {James S.} and Julia Steinberger and Scott Baker",

note = "Funding Information: Supported by the National Institutes of Health (grants R01 CA113930 [to J.S.] and R01CA112530 [to K.S.B.]), the General Clinical Research Center Program (grant M01‐RR00400), National Center for Research Resources (grant 1UL1‐RR033183), and the Clinical and Translational Science Institute at the University of Minnesota‐Twin Cities (grant UL1TR000114). Statistical support was provided by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114. Publisher Copyright: {\textcopyright} 2021 Wiley Periodicals LLC.",

year = "2022",

month = feb,

doi = "10.1111/petr.14130",

language = "English (US)",

volume = "26",

journal = "Pediatric transplantation",

issn = "1397-3142",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - The role of FSH in body composition in hematopoietic cell transplant recipients

AU - Roelofs, Erica J.

AU - Dengel, Donald R.

AU - Wang, Qi

AU - Hodges, James S.

AU - Steinberger, Julia

AU - Baker, Scott

N1 - Funding Information: Supported by the National Institutes of Health (grants R01 CA113930 [to J.S.] and R01CA112530 [to K.S.B.]), the General Clinical Research Center Program (grant M01‐RR00400), National Center for Research Resources (grant 1UL1‐RR033183), and the Clinical and Translational Science Institute at the University of Minnesota‐Twin Cities (grant UL1TR000114). Statistical support was provided by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114. Publisher Copyright: © 2021 Wiley Periodicals LLC.

PY - 2022/2

Y1 - 2022/2

N2 - BACKGROUND: Childhood cancer survivors who received a hematopoietic cell transplantation (HCT) are at increased risk for follicle-stimulating hormone (FSH) abnormalities, which may have a significant negative impact on bone health and body composition. This study's purpose was to examine FSH and body composition in HCT recipients, non-HCT recipients and healthy controls.METHODS: The study included HCT recipients (n = 24), non-HCT recipients (n = 309), and a control group of healthy siblings (n = 211) all aged 9-18 years. A fasting blood sample was collected to measure FSH. All participants underwent a dual X-ray absorptiometry scan to assess total and regional percent fat, lean mass (LM), fat mass (FM), bone mineral content (BMC), bone mineral density (BMD), and visceral adipose tissue (VAT) mass.RESULTS: FSH was significantly higher in HCT recipients compared to non-HCT recipients and healthy controls. HCT recipients had significantly lower total body weight, total LM, arm and leg LM, BMC and BMD compared to non-HCT recipients and healthy controls (p < .05). Non-HCT recipients had significantly higher total, trunk, android, gynoid, arm and leg FM compared to healthy controls. Also, healthy controls had significantly lower VAT mass compared to non-HCT recipients.CONCLUSIONS: This study's results show that HCT recipients have significant reductions in BMD, worse body composition, and abnormal FSH levels compared to non-HCT recipients and healthy controls.

AB - BACKGROUND: Childhood cancer survivors who received a hematopoietic cell transplantation (HCT) are at increased risk for follicle-stimulating hormone (FSH) abnormalities, which may have a significant negative impact on bone health and body composition. This study's purpose was to examine FSH and body composition in HCT recipients, non-HCT recipients and healthy controls.METHODS: The study included HCT recipients (n = 24), non-HCT recipients (n = 309), and a control group of healthy siblings (n = 211) all aged 9-18 years. A fasting blood sample was collected to measure FSH. All participants underwent a dual X-ray absorptiometry scan to assess total and regional percent fat, lean mass (LM), fat mass (FM), bone mineral content (BMC), bone mineral density (BMD), and visceral adipose tissue (VAT) mass.RESULTS: FSH was significantly higher in HCT recipients compared to non-HCT recipients and healthy controls. HCT recipients had significantly lower total body weight, total LM, arm and leg LM, BMC and BMD compared to non-HCT recipients and healthy controls (p < .05). Non-HCT recipients had significantly higher total, trunk, android, gynoid, arm and leg FM compared to healthy controls. Also, healthy controls had significantly lower VAT mass compared to non-HCT recipients.CONCLUSIONS: This study's results show that HCT recipients have significant reductions in BMD, worse body composition, and abnormal FSH levels compared to non-HCT recipients and healthy controls.

UR - http://www.scopus.com/inward/record.url?scp=85114367683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85114367683&partnerID=8YFLogxK

U2 - 10.1111/petr.14130

DO - 10.1111/petr.14130

M3 - Article

C2 - 34486806

AN - SCOPUS:85114367683

SN - 1397-3142

VL - 26

JO - Pediatric transplantation

JF - Pediatric transplantation

IS - 1

M1 - e14130

ER -

The role of FSH in body composition in hematopoietic cell transplant recipients

Abstract

Bibliographical note

PubMed: MeSH publication types

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this